Search results for "COMORBIDITY"

showing 10 items of 799 documents

P145 Inflammatory Bowel Disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: resu…

2021

Abstract Background Little is known regarding the outcomes of inflammatory bowel disease (IBD) patients who required surgery during the outbreak of Coronavirus disease 19 (COVID-19). This study aimed to compare outcomes of IBD patients undergoing surgery in COVID-19-treatment and COVID-19-free hospitals. Methods Retrospective study involving patients undergoing IBD surgery in seven centres (six COVID-19-treatment hubs and one COVID-free hospital) across 5 European countries during the period of highest reduction of elective activity due to the first peak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Predictive variables of the risk of moderate-to-severe postope…

medicine.medical_specialtyCrohn's diseaseReferralbusiness.industryGastroenterologyOutbreakGeneral MedicineDiseasemedicine.diseaseClinical: Diagnosis and OutcomeComorbidityUlcerative colitisInflammatory bowel diseasePoster presentationsSurgeryIntensive caremedicinebusinessAcademicSubjects/MED00260Journal of Crohn's and Colitis
researchProduct

Differentiating hypochondriasis from panic disorder

2003

Hypochondriasis and panic disorder are both characterized by prevalent health anxieties and illness beliefs. Therefore, the question as to whether they represent distinct nosological entities has been raised. This study examines how clinical characteristics can be used to differentiate both disorders, taking the possibility of mixed symptomatologies (comorbidity) into account. We compared 46 patients with hypochondriasis, 45 with panic disorder, and 21 with comorbid hypochondriasis plus panic disorder. While panic patients had more comorbidity with agoraphobia, hypochondriasis was more closely associated with somatization. Patients with panic disorder were less pathological than hypochondri…

medicine.medical_specialtyCultureComorbiditybehavioral disciplines and activitiesInternational Classification of DiseasesSurveys and Questionnairesmental disordersmedicineHumansSomatoform DisordersPsychiatryAgoraphobiaPanic disorderPanicMiddle Agedmedicine.diseaseAnxiety DisordersComorbidityhumanitiesHypochondriasisDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyPanic DisorderAnxietymedicine.symptomPsychologyAttitude to HealthSomatizationAnxiety disorderPsychopathologyAgoraphobiaClinical psychologyJournal of Anxiety Disorders
researchProduct

A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes

2015

Contains fulltext : 152084.pdf (Publisher’s version ) (Open Access) BACKGROUND: Optimal glucose-lowering therapy in type 2 diabetes mellitus requires a patient-specific approach. Although a good framework, current guidelines are insufficiently detailed to address the different phenotypes and individual needs of patients seen in daily practice. We developed a patient-specific decision support tool based on a systematic analysis of expert opinion. MATERIALS AND METHODS: Based on the American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) 2012 position statement, a panel of 12 European experts rated the appropriateness (RAND/UCLA Appropriateness Method) of tre…

medicine.medical_specialtyDecision support systemEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]MEDLINEType 2 diabetesComorbidityHypoglycemiaGlucagon-Like Peptide-1 ReceptorBody Mass IndexEndocrinologyLife ExpectancyClinical ProtocolsInternal medicineHealth careReceptors GlucagonMedicineHumansHypoglycemic AgentsInsulinPrecision MedicineIntensive care medicineExpert TestimonyReimbursementComputingMilieux_MISCELLANEOUSGlycated HemoglobinDipeptidyl-Peptidase IV InhibitorsPioglitazonebusiness.industryDrug SubstitutionType 2 Diabetes MellitusMetabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6]Original ArticlesPrecision medicinemedicine.diseaseDecision Support Systems ClinicalHypoglycemiaMetformin3. Good healthEuropeMedical Laboratory TechnologyEndocrinologySulfonylurea CompoundsDiabetes Mellitus Type 2Drug Therapy CombinationThiazolidinedionesbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

The genetic epidemiology of unipolar depression and panic disorder.

1993

medicine.medical_specialtyDepressive DisorderBipolar DisorderPanic disorderIncidenceComorbiditymedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesGenetic epidemiologyGermanyAdoptionmedicineDiseases in TwinsHumansPanic DisorderPharmacology (medical)PsychiatryPsychologyDepression (differential diagnoses)International clinical psychopharmacology
researchProduct

SGLT2 inhibitors in T2D and associated comorbidities - differentiating within the class

2019

Abstract Background For patients with type 2 diabetes (T2D), cardiovascular disease (CVD) is the single most common cause of mortality. In 2008 and 2012, the Federal Drug Administration (FDA) and the European Medicines Agency (EMA) respectively mandated cardiovascular outcomes trials (CVOTs) on all new anti-diabetic agents, as prospective trials statistically powered to rule out excess cardiovascular risk in patients with T2D. Unexpectedly, some of these CVOTs have demonstrated not only cardiovascular safety, but also cardioprotective effects, as was first shown for the SGLT2 inhibitor empagliflozin in EMPA-REG OUTCOME. Expert opinion To debate newly available CVOT data and to put them into…

medicine.medical_specialtyDiabetes mellitus type 2 ; drug therapy ; Cardiovascular diseases ; drug therapy ; Canagliflozin ; therapeutic use ; Benzhydryl compounds ; therapeutic use ; Glucosides ; therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors ; therapeutic useEndocrinology Diabetes and MetabolismEmpagliflozin610 Medicine & health030209 endocrinology & metabolismContext (language use)ComorbidityType 2 diabetesDiseaseCanagliflozin ; Cardiovascular disease ; Dapagliflozin ; Empagliflozin ; SGLT2 inhibitor ; Type 2 diabetes.lcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDiabetes mellitusCorrespondenceEmpagliflozinHumansMedicine030212 general & internal medicineCanagliflozinDapagliflozinIntensive care medicineSodium-Glucose Transporter 2 InhibitorsCanagliflozinlcsh:RC648-665business.industryIncidence616.379-008.64 [udc]Type 2 diabetesSGLT2 inhibitorGeneral MedicineDapagliflozinCardiovascular diseasePrognosismedicine.disease3. Good healthEastern europeanDiabetes Mellitus Type 2chemistryCardiovascular Diseasesbusinessmedicine.drug
researchProduct

Prevalence Rate and Course of Symptoms of Disruptive Mood Dysregulation Disorder (DMDD)

2018

Abstract. Objective: According to DSM-5, Disruptive Mood Dysregulation Disorder (DMDD) is characterized by chronic temper outbursts and irritable moods. So far, little is known about its prevalence rate, course and influence on individual well-being. We assessed the prevalence rates of DMDD symptoms during adulthood and primary school age – the latter retrospectively – and studied their relationship with psychiatric disorders and socioeconomic variables. Methods: A total of 2,413 subjects, aged 18–94 years, participated in this population-based, representative study based on self-reports. Results: 12 (0.50 %) subjects reported elevated DMDD symptoms during adulthood, and 19 (0.79 %) report…

medicine.medical_specialtyDisruptive mood dysregulation disorderCross-sectional study05 social sciencesGeneral Medicinemedicine.diseaseComorbidity03 medical and health sciencesPsychiatry and Mental healthClinical Psychology0302 clinical medicineMood disordersPediatrics Perinatology and Child HealthmedicineAnxiety0501 psychology and cognitive sciencesIrritable MoodYoung adultmedicine.symptomPsychologyPsychiatry030217 neurology & neurosurgeryDepression (differential diagnoses)050104 developmental & child psychologyClinical psychologyZeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
researchProduct

Visual Attention, Orthographic Word Recognition, and Executive Functioning in Children With ADHD, Dyslexia, or ADHD + Dyslexia

2019

Objective: The current study examined the differences in visual selective attention, orthographic word recognition, and executive functioning. Method: One hundred and forty Ecuadorian children in third and fifth grades of elementary school (8-10 years old) participated in the study—35 with only dyslexia (DD), 35 with the combined type of attention deficit and hyperactivity disorder (ADHD-C), 35 with disorders (DD + ADHD-C), and 35 typical development children (TD). Results: The Ecuadorian children with DD and/or ADHD-C in this age range usually have difficulties in visual selective attention, and also in orthographic word recognition. The executive functioning results showed that such func…

medicine.medical_specialtyDissociation (neuropsychology)PopulationComorbidityAudiologybehavioral disciplines and activitiesDyslexiaExecutive Function03 medical and health sciences0302 clinical medicinemental disordersDevelopmental and Educational PsychologymedicineHumansVisual attentionSelective attentionChildeducationeducation.field_of_study05 social sciencesDyslexia050301 educationmedicine.diseaseComorbidityClinical PsychologyAttention Deficit Disorder with HyperactivityWord recognitionAttention deficitPsychology0503 education030217 neurology & neurosurgeryJournal of Attention Disorders
researchProduct

No paradox, no progress: inverse cancer comorbidity in people with other complex diseases.

2011

Salvador Martínez [et al.]. 5 p., 2 tables and references.

medicine.medical_specialtyDown syndromeAnorexia NervosaNeuregulin-1DiseaseComorbidity03 medical and health sciences0302 clinical medicineAlzheimer DiseaseNeoplasmsEpidemiologymedicineHumansGenetic Predisposition to DiseasePsychiatryComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesbusiness.industryCancerParkinson Diseasemedicine.disease[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]Comorbidity3. Good healthOncologySchizophreniaAnorexia nervosa (differential diagnoses)SchizophreniaAlzheimer's diseaseDown Syndromebusiness030217 neurology & neurosurgeryChromosomes Human Pair 8The Lancet. Oncology
researchProduct

Dysfunctional rearing in community and clinic based populations with eating problems: prevalence and mediating role of psychiatric morbidity

2006

Objective To assess the presence of dysfunctional rearing in adolescent females with ED and the role of psychiatric comorbidity as mediating variable of this relationship. Method Administration of a rearing-attitude questionnaire (EMBU-A) and a standardized psychiatric evaluation. Data from a two-phase epidemiological study and from ED inpatients. Case diagnosis was performed using wide DSM-IV criteria (n = 29). Controls were matched by age and school. Results Significant differences were found between EDs subjects and controls on the scales of emotional warmth, overprotection, and rejection. There were no rearing differences between community cases and hospitalized patients. Paternal rejec…

medicine.medical_specialtyDysfunctional familymedicine.diseaseComorbidityStructural equation modelingPsychological evaluationPsychiatry and Mental healthClinical PsychologyEating disordersEpidemiology of child psychiatric disordersEpidemiologymedicinePsychiatryPsychologyEating problemsClinical psychologyEuropean Eating Disorders Review
researchProduct

Anthropometric parameters and permanent remission of comorbidities 10 years after open gastric bypass in a cohort with high prevalence of super-obesi…

2017

Abstract Background and aim Roux-en-Y gastric bypass (RYGB) is an effective treatment for weight loss in patients with morbid obesity. However, few studies have assessed its long-term efficacy in super-obese patients. The study objective was to analyse the long-term effectiveness of RYGB and its effect on improvement of comorbidities after 10 years of follow-up, and to compare the results depending on baseline BMI ( 2 vs ≥50 kg/m 2 ). Patients and methods A retrospective study was conducted in 63 patients referred for RYGB with a 10-year or longer follow-up period. Mean BMI before surgery was 55 kg/m 2 . Results Mean BMI decreased to 38.1 kg/m 2 at 10 years of follow-up. The success rates a…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismGastric bypassGastric Bypass030209 endocrinology & metabolismComorbidityBody Mass Index03 medical and health sciencesPostoperative Complications0302 clinical medicineEndocrinologyWeight lossDiabetes mellitusInternal medicineWeight LossPrevalencemedicinePostoperative Period030212 general & internal medicineDyslipidemiasSleep Apnea ObstructiveNutrition and Dieteticsbusiness.industryRemission Inductionnutritional and metabolic diseasesSleep apneaRetrospective cohort studymedicine.diseaseComorbidityObesity MorbidSurgeryTreatment OutcomeDiabetes Mellitus Type 2SpainHypertensionCohortmedicine.symptombusinessDyslipidemiaFollow-Up StudiesEndocrinología, Diabetes y Nutrición
researchProduct